Pages that link to "Q48335925"
Jump to navigation
Jump to search
The following pages link to Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective (Q48335925):
Displaying 33 items.
- Degradation and glycemic effects of His(7)-glucitol glucagon-like peptide-1(7-36)amide in obese diabetic ob/ob mice. (Q31665544) (← links)
- Local, exendin-(9-39)-insensitive, site of action of GLP-1 in canine ileum (Q33184111) (← links)
- Glucagon-Like Peptide-1 Synthetic Analogs: New Therapeutic Agents for Use in the Treatment of Diabetes Mellitus (Q34026346) (← links)
- Preclinical developments in type 2 diabetes (Q34977231) (← links)
- Immunoelectron microscopic observation of chicken glucagon-like peptide (GLP)-1-containing cells in tissues derived from thin section, paraffin block and conventional method (Q35047752) (← links)
- Physiology of Incretins in Health and Disease (Q35760279) (← links)
- Structure and function studies of glucagon-like peptide-1 (GLP-1): the designing of a novel pharmacological agent for the treatment of diabetes. (Q36106470) (← links)
- The incretins: a link between nutrients and well-being (Q36118673) (← links)
- Forgotten and novel aspects in pancreas development (Q36370510) (← links)
- Incretins and the development of type 2 diabetes (Q36560963) (← links)
- Dietary synergies in appetite control: distal gastrointestinal tract (Q36576609) (← links)
- Design, synthesis and crystallization of a novel glucagon analog as a therapeutic agent (Q36585213) (← links)
- Injectable protease-operated depots of glucagon-like peptide-1 provide extended and tunable glucose control (Q36637567) (← links)
- Is Glucagon-like peptide-1, an agent treating diabetes, a new hope for Alzheimer's disease? (Q36860616) (← links)
- Saxagliptin Improves Glucose Tolerance but not Survival in a Murine Model of Dilated Cardiomyopathy (Q36939647) (← links)
- Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes (Q37900307) (← links)
- Protein hydrolysates stimulate proglucagon gene transcription in intestinal endocrine cells via two elements related to cyclic AMP response element (Q38342423) (← links)
- Food protein-derived bioactive peptides in management of type 2 diabetes (Q38543982) (← links)
- Protein based therapeutic delivery agents: Contemporary developments and challenges (Q39273739) (← links)
- Ultrastructural study on colocalization of glucagon-like peptide (GLP)-1 with GLP-2 in chicken intestinal L-cells (Q41999792) (← links)
- A depot-forming glucagon-like peptide-1 fusion protein reduces blood glucose for five days with a single injection (Q42280003) (← links)
- Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes (Q42490547) (← links)
- Potentiation and prolongation of the insulinotropic action of glucagon-like peptide 1 by methyl pyruvate or dimethyl ester of L-glutamic acid in a type 2 diabetes animal model (Q43912166) (← links)
- S 23521 decreases food intake and body weight gain in diet-induced obese rats (Q45145890) (← links)
- The dipeptidyl peptidase IV inhibitor NVP-DPP728 reduces plasma glucagon concentration in cats (Q46172095) (← links)
- On the relationship between glucose absorption and glucose-stimulated secretion of GLP-1, neurotensin, and PYY from different intestinal segments in the rat. (Q47128724) (← links)
- The influence of restricted feeding on glucagon-like peptide-1 (GLP-1)-containing cells in the chicken small intestine (Q47890635) (← links)
- Relationship between metabolic syndrome and meal-induced glucagon like peptide-1 response in type 1 diabetic patients1-1. (Q51318715) (← links)
- Basal GLP-1 levels in morbidly obese patients following biliopancreatic diversion surgery. (Q51353310) (← links)
- Temporal changes in glucose and insulin homeostasis after biliopancreatic diversion and laparoscopic adjustable gastric banding (Q51363825) (← links)
- The metabolic syndrome influences the response to incretin-based therapies. (Q51373270) (← links)
- Influences of protein ingestion on glucagon-like peptide (GLP)-1-immunoreactive endocrine cells in the chicken ileum (Q57110457) (← links)
- 1,5-Anhydro-d-fructose increases glucose tolerance by increasing glucagon-like peptide-1 and insulin in mice (Q58448791) (← links)